1 Min Read
Feb 7 (Reuters) - SIGA Technologies Inc:
* SIGA TECHNOLOGIES ANNOUNCES FDA ACCEPTS NDA AND GRANTS PRIORITY REVIEW FOR ORAL TPOXX TO TREAT SMALLPOX Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.